Business Today

Big Pharma on the backfoot in India
Business Today
In March, the Indian Patent Office granted Hyderabad-based Natco Pharma a "compulsory licence" to sell a generic version of German company Bayer AG's kidney and liver cancer drug, Nexavar. It was the first instance of an Indian company getting a ...
India rejects AstraZeneca patent appeal on IressaPharmaTimes
Natco Pharma hits record high after IPAB dismisses AstraZeneca drug appealBusiness Standard
Patents appeal board rejects AstraZeneca's plea on cancer drugEconomic Times
Times of India
all 54 news articles »